Claritev Shares Up on Better-Than-Expected 3Q Revenue, Raised Guidance

Dow Jones

Nov 07

By Terell Wright

Claritev shares rose Friday after the company's third-quarter revenue exceeded expectations, leading to a raised full-year revenue outlook.

Shares rose 12.8% to $69.87 in recent trading, and have risen fourfold year-to-date.

The McLean, Va.-based healthcare technology company narrowed its third-quarter loss to $69.8 million, or $4.23 a share, from a loss of $391.5 million, or $24.25 a share, a year earlier. Analysts expected a loss of $3.59 a share.

Revenue rose 6.7% to $246 million, beating Wall Street's estimate of $235.8 million.

It now expects revenue to rise 2.8% to 3.2% for the year, compared with a prior view of up to 2%.

Write to Terell Wright at terell.wright@wsj.com

(END) Dow Jones Newswires

November 07, 2025 10:39 ET (15:39 GMT)

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2581884025"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2581884025\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2581884025?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-07 23:39","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2581884025","market":"fut","top_or_hot":-1,"title":"Claritev Shares Up on Better-Than-Expected 3Q Revenue, Raised Guidance","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  By Terell Wright \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Claritev shares rose Friday after the company's third-quarter revenue exceeded expectations, leading to a raised full-year revenue outlook. \n</p>\n<p>\n  Shares rose 12.8% to $69.87 in recent trading, and have risen fourfold year-to-date. \n</p>\n<p>\n  The McLean, Va.-based healthcare technology company narrowed its third-quarter loss to $69.8 million, or $4.23 a share, from a loss of $391.5 million, or $24.25 a share, a year earlier. Analysts expected a loss of $3.59 a share. \n</p>\n<p>\n  Revenue rose 6.7% to $246 million, beating Wall Street's estimate of $235.8 million. \n</p>\n<p>\n  It now expects revenue to rise 2.8% to 3.2% for the year, compared with a prior view of up to 2%. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Write to Terell Wright at terell.wright@wsj.com \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  November 07, 2025 10:39 ET (15:39 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Claritev Shares Up on Better-Than-Expected 3Q Revenue, Raised Guidance</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nClaritev Shares Up on Better-Than-Expected 3Q Revenue, Raised Guidance\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2025-11-07 23:39</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  By Terell Wright \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Claritev shares rose Friday after the company's third-quarter revenue exceeded expectations, leading to a raised full-year revenue outlook. \n</p>\n<p>\n  Shares rose 12.8% to $69.87 in recent trading, and have risen fourfold year-to-date. \n</p>\n<p>\n  The McLean, Va.-based healthcare technology company narrowed its third-quarter loss to $69.8 million, or $4.23 a share, from a loss of $391.5 million, or $24.25 a share, a year earlier. Analysts expected a loss of $3.59 a share. \n</p>\n<p>\n  Revenue rose 6.7% to $246 million, beating Wall Street's estimate of $235.8 million. \n</p>\n<p>\n  It now expects revenue to rise 2.8% to 3.2% for the year, compared with a prior view of up to 2%. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Write to Terell Wright at terell.wright@wsj.com \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  November 07, 2025 10:39 ET (15:39 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"CTEV","symbol_name":"Claritev Corporation","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2581884025","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2581884025","pubTimestamp":1762529940,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Claritev shares rose Friday after the company's third-quarter revenue exceeded expectations, leading to a raised full-year revenue outlook.Shares rose 12.8% to $69.87 in recent trading, and have risen fourfold year-to-date.The McLean, Va.-based healthcare technology company narrowed its third-quarter loss to $69.8 million, or $4.23 a share, from a loss of $391.5 million, or $24.25 a share, a year earlier. Analysts expected a loss of $3.59 a share.Revenue rose 6.7% to $246 million, beating Wall Street's estimate of $235.8 million.It now expects revenue to rise 2.8% to 3.2% for the year, compared with a prior view of up to 2%.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"CTEV":"Claritev Corporation","BK4167":"医疗保健技术"},"translate_title":"Claritev股价因第三季度收入好于预期并上调指引而上涨","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CTEV":0.9},"content_text":"By Terell Wright \n\n\n \n\n\n  Claritev shares rose Friday after the company's third-quarter revenue exceeded expectations, leading to a raised full-year revenue outlook. \n\n\n  Shares rose 12.8% to $69.87 in recent trading, and have risen fourfold year-to-date. \n\n\n  The McLean, Va.-based healthcare technology company narrowed its third-quarter loss to $69.8 million, or $4.23 a share, from a loss of $391.5 million, or $24.25 a share, a year earlier. Analysts expected a loss of $3.59 a share. \n\n\n  Revenue rose 6.7% to $246 million, beating Wall Street's estimate of $235.8 million. \n\n\n  It now expects revenue to rise 2.8% to 3.2% for the year, compared with a prior view of up to 2%. \n\n\n \n\n\n  Write to Terell Wright at terell.wright@wsj.com \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  November 07, 2025 10:39 ET (15:39 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}